Scientists at the UMass Medical School have identified a novel gene that calibrates circadian rhythms in the experimental model organism Drosophila, and that may have potential implications for neurodegenerative disorders in humans including spinocerebellar ataxia, amyotrophic lateral sclerosis (ALS) and Parkinson’s disease.